Wnt Signaling Inhibitors As Therapeutic Approach in Ischemic Heart Disease

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2025 Jan 8

PMID 39770047

Authors

Barbora Botanska Svetlakova

Viktoria Pecnikova Liskova

Miroslav Barancik

Affiliations

Soon will be listed here.

Abstract

Wnt (wingless-type MMTV integration site family) signaling is an evolutionary conserved system highly active during embryogenesis, but in adult hearts has low activities under normal conditions. It is essential for a variety of physiological processes including stem cell regeneration, proliferation, migration, cell polarity, and morphogenesis, thereby ensuring homeostasis and regeneration of cardiac tissue. Its dysregulation and excessive activation during pathological conditions leads to morphological and functional changes in the heart resulting in impaired myocardial regeneration under pathological conditions such as myocardial infarction, heart failure, and coronary artery disease. Several groups of Wnt inhibitors have demonstrated the ability to modulate the Wnt pathway and thereby significantly reduce fibrosis and improve cardiac function after myocardial ischemia. Their inhibitory effect can be realized at multiple levels, which include the inhibition of Wnt ligands, the inhibition of Frizzled receptors, the stabilization of the β-catenin destruction complex, and the disruption of nuclear β-catenin interactions. In this review, we overview the function of Wnt signaling in responses of cardiac cells to pathological conditions, especially ischemic heart disease, with an emphasis on the use of inhibitors of this signaling as a therapeutic approach. Finally, we summarize the current knowledge about the potential of the targeting of Wnt signaling in therapeutic applications.

References

Colella B, Faienza F, Carinci M, DAlessandro G, Catalano M, Santoro A . Autophagy induction impairs Wnt/β-catenin signalling through β-catenin relocalisation in glioblastoma cells. Cell Signal. 2018; 53:357-364. DOI: 10.1016/j.cellsig.2018.10.017. View

Malekar P, Hagenmueller M, Anyanwu A, Buss S, Streit M, Weiss C . Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Hypertension. 2010; 55(4):939-45. DOI: 10.1161/HYPERTENSIONAHA.109.141127. View

Lin K, Wang S, Julius M, Kitajewski J, Moos Jr M, Luyten F . The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc Natl Acad Sci U S A. 1997; 94(21):11196-200. PMC: 23413. DOI: 10.1073/pnas.94.21.11196. View

Blankesteijn W, van de Schans V, Ter Horst P, Smits J . The Wnt/frizzled/GSK-3 beta pathway: a novel therapeutic target for cardiac hypertrophy. Trends Pharmacol Sci. 2008; 29(4):175-80. DOI: 10.1016/j.tips.2008.01.003. View

Wang H, Segersvard H, Siren J, Perttunen S, Immonen K, Kosonen R . Tankyrase Inhibition Attenuates Cardiac Dilatation and Dysfunction in Ischemic Heart Failure. Int J Mol Sci. 2022; 23(17). PMC: 9456217. DOI: 10.3390/ijms231710059. View

DAmico R, Cordaro M, Siracusa R, Impellizzeri D, Salinaro A, Scuto M . Wnt/β-Catenin Pathway in Experimental Model of Fibromyalgia: Role of Hidrox. Biomedicines. 2021; 9(11). PMC: 8615925. DOI: 10.3390/biomedicines9111683. View

Laeremans H, Hackeng T, van Zandvoort M, Thijssen V, Janssen B, Ottenheijm H . Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation. 2011; 124(15):1626-35. DOI: 10.1161/CIRCULATIONAHA.110.976969. View

Nakashima T, Ohkusa T, Okamoto Y, Yoshida M, Lee J, Mizukami Y . Rapid electrical stimulation causes alterations in cardiac intercellular junction proteins of cardiomyocytes. Am J Physiol Heart Circ Physiol. 2014; 306(9):H1324-33. DOI: 10.1152/ajpheart.00653.2013. View

Planutiene M, Planutis K, Holcombe R . Lymphoid enhancer-binding factor 1, a representative of vertebrate-specific Lef1/Tcf1 sub-family, is a Wnt-beta-catenin pathway target gene in human endothelial cells which regulates matrix metalloproteinase-2 expression and promotes endothelial.... Vasc Cell. 2011; 3:28. PMC: 3269378. DOI: 10.1186/2045-824X-3-28. View

10.

Hoang B, Kubo T, Healey J, Yang R, Nathan S, Kolb E . Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res. 2004; 64(8):2734-9. DOI: 10.1158/0008-5472.can-03-1952. View

11.

Bergmann M . WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development. Circ Res. 2010; 107(10):1198-208. DOI: 10.1161/CIRCRESAHA.110.223768. View

12.

Cleutjens J, Blankesteijn W, Daemen M, Smits J . The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res. 2000; 44(2):232-41. DOI: 10.1016/s0008-6363(99)00212-6. View

13.

Duan J, Gherghe C, Liu D, Hamlett E, Srikantha L, Rodgers L . Wnt1/βcatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. EMBO J. 2011; 31(2):429-42. PMC: 3261567. DOI: 10.1038/emboj.2011.418. View

14.

Czepiel M, Diviani D, Jazwa-Kusior A, Tkacz K, Rolski F, Smolenski R . Angiotensin II receptor 1 controls profibrotic Wnt/β-catenin signalling in experimental autoimmune myocarditis. Cardiovasc Res. 2021; 118(2):573-584. PMC: 8803091. DOI: 10.1093/cvr/cvab039. View

15.

Ma L, Wang H . Mitogen-activated protein kinase p38 regulates the Wnt/cyclic GMP/Ca2+ non-canonical pathway. J Biol Chem. 2007; 282(39):28980-28990. DOI: 10.1074/jbc.M702840200. View

16.

Methatham T, Tomida S, Kimura N, Imai Y, Aizawa K . Inhibition of the canonical Wnt signaling pathway by a β-catenin/CBP inhibitor prevents heart failure by ameliorating cardiac hypertrophy and fibrosis. Sci Rep. 2021; 11(1):14886. PMC: 8295328. DOI: 10.1038/s41598-021-94169-6. View

17.

Yin C, Ye Z, Wu J, Huang C, Pan L, Ding H . Elevated Wnt2 and Wnt4 activate NF-κB signaling to promote cardiac fibrosis by cooperation of Fzd4/2 and LRP6 following myocardial infarction. EBioMedicine. 2021; 74:103745. PMC: 8669316. DOI: 10.1016/j.ebiom.2021.103745. View

18.

Mirotsou M, Zhang Z, Deb A, Zhang L, Gnecchi M, Noiseux N . Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A. 2007; 104(5):1643-8. PMC: 1785280. DOI: 10.1073/pnas.0610024104. View

19.

He J, Wo D, Ma E, Wang Q, Chen J, Gao Q . Huoxin pill prevents excessive inflammation and cardiac dysfunction following myocardial infarction by inhibiting adverse Wnt/β‑catenin signaling activation. Phytomedicine. 2022; 104:154293. DOI: 10.1016/j.phymed.2022.154293. View

20.

De Jaime-Soguero A, Abreu de Oliveira W, Lluis F . The Pleiotropic Effects of the Canonical Wnt Pathway in Early Development and Pluripotency. Genes (Basel). 2018; 9(2). PMC: 5852589. DOI: 10.3390/genes9020093. View